FDA releases statistics for the first two quarters of FY 2021 on actions relating to section 505(j) ANDAs.
FDA releases a nine-item Form-483 less than 24 hours after it completed an inspection of Emergent BioSolutions Baltimore manufacturing plant that show...
FDA has approved the Medtronic Pipeline Flex embolization device with the companys proprietary Shield Technology.
FDA denies a Cell2in petition seeking inclusion of GSH monitoring in certain guidances as a means to measure the potency of cellular therapy products.
FDA clears a LivaNova 510(k) for B-Capta, an in-line, blood-gas monitoring system integrated into its S5 heart-lung machine.
FDA clears a Johnson & Johnson Vision 510(k) for its Veritas Vision System, a phacoemulsification (cataract surgery) device that allows surgeons to gu...
Two Yale Law School professors suggest changes to FDA to create a clinical trial publicity regime exposing confidential data.
CBER director Peter Marks says enforcement discretion for IND and premarket application requirements for certain regenerative medicine products will n...